Question 1

How many shares of DNLI does BAKER BROS. ADVISORS LP own?

Accepted Answer

As of 2026-Q2, BAKER BROS. ADVISORS LP holds 3.7M shares of DNLI (DENALI THERAPEUTICS INC).

Question 2

What is BAKER BROS. ADVISORS LP's DNLI position worth?

Accepted Answer

As of 2026-Q2, BAKER BROS. ADVISORS LP's DNLI position is worth $96M.

Question 3

Is BAKER BROS. ADVISORS LP buying or selling DNLI?

Accepted Answer

In 2026-Q2, BAKER BROS. ADVISORS LP increased their DNLI position (+0.1% change in shares).

Question 4

When did BAKER BROS. ADVISORS LP first buy DNLI?

Accepted Answer

Based on available 13F filings, BAKER BROS. ADVISORS LP first reported a position in DNLI in 2024-Q3. They have held the position across 26 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	3.7M	+0.1%	$96M	0.5%	$25.72	36
2026-Q1	Unchanged	3.7M	0.0%	$71.6M	0.4%	$20.02	0
2025-Q4	Unchanged	3.7M	0.0%	$61.6M	0.4%	$16.41	0
2025-Q3	Unchanged	3.7M	0.0%	$54.2M	0.4%	$14.52	0
2025-Q2	Unchanged	3.7M	0.0%	$52.2M	0.5%	$14.10	0
2025-Q1	Unchanged	3.7M	0.0%	$50.7M	0.6%	$14.78	0
2024-Q4	Unchanged	3.7M	0.0%	$76.1M	0.8%	$20.24	0
2024-Q3	Unchanged	3.7M	0.0%	$108.7M	1.1%	$29.43	0